915124-86-6

915124-86-6 structure

Name: Telmisartan Amide
Chemical Name: 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzamide
CAS Number: 915124-86-6
Molecular Formula: C₃₃H₃₁N₅O
Molecular Weight: 513.63
Catalog: Signaling Pathways Cell Cycle/DNA Damage PPAR
Create Date: 2017-01-13 02:49:25
Modify Date: 2026-07-16 19:39:20
PPARγ agonist 5 (Compound 1) is a potent and selective agonist of PPARγ. PPARγ agonist 5 has the potential for the research of cancer diseases[1].

Name	2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzamide
Synonyms	[1,1'-Biphenyl]-2-cboxaMide, 4'-[(1,4'-diMethyl-2'-propyl[2,6'-bi-1H-benziMidazol]-1'-yl) Methyl] 4′-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl][1,1′-biphenyl Telmistan Impurity 6(Telmistan Impurity F) Telmistan Impurity FQ: What is Telmistan Impurity F Q: What is the CAS Number of Telmistan Impurity F Q: What is the storage condition of Telmistan Impurity F Q: What e the applications of Telmistan Impurity F 2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl] methyl}phenyl)benzamide Telmisatran impurity F Telmistan Imp. F : 4'-[[4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-cboxamide Telmistan Intermediates 4′-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl][1,1′-biphenyl]-2-cboxamide (Telmistan Amide) carboxamidotelmisartan UNII-0C9IQ6NHUX TELMISTAN IMPURITY F (AMIDE) Telmistan Impurity F（） TelMistan IMpurity F Telmistan Impurity F (Telmistan Amide) Telmisartan Impurity 6 4'-((1,7'-dimethyl-2'-propyl-1H,3',5'-bibenzo[d]imidazol-3'-yl)methyl)biphenyl-2-cboxamide 4'-[(1,4'-DiMethyl-2'-propyl[2,6'-bi-1H-benziMidazol]-1'-yl)Methyl][1,1'-biphenyl]-2-cboxaMide Telmistan Amide Telmistan Impurity F/ Telmistan amide PPγ agonist 5

Description	PPARγ agonist 5 (Compound 1) is a potent and selective agonist of PPARγ. PPARγ agonist 5 has the potential for the research of cancer diseases[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> PPAR
References	[1]. Schoepf AM, et al. Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells. Eur J Med Chem. 2020 Jun 1;195:112258.

144702-27-2

~88%

915124-86-6

Literature: CHEMAGIS LTD. Patent: US2006/264491 A1, 2006 ; Location in patent: Page/Page column 4 ;